Introduction: Surgical resection is the treatment of choice for pancreatic ductal adenocarcinoma (PDA). However, in case of venous tumor in-volvement, carcinomas are classified as borderline resectable and their preferential therapy remains controversial. The purpose of this study is to analyze the effectiveness of the surgical approach with simultaneous venous resection regarding perioperative outcome and long-term survival. Patients and methods: All patients that underwent pancreatoduodenectomy (PD) for PDA at our institution between 02/2002 and 12/2016 were analyzed retrospectively. A matched-pair analysis between patients that underwent PD with simultaneous venous resection (PDVR) and standard PD was performed to compare perioperative parameters, survival and factors relevant to long-term survival. Results: The study included 142 patients: 71 underwent PDVR and 71 underwent standard PD. Venous tumor infiltration could histopathologically be confirmed in 21 patients (29.58%). PDVR wasn’t associated with a higher rate of postoperative complications (56.34% for both groups), severe postoperative complications (28.17% vs. 23.94%) and mortality (5.63% vs. 9.86%) compared to standard PD. Median overall survival of both groups was 17 months (95% CI 10.89 - 23.11), without statistical significance between the two groups (PD 22 months, 95% CI 16.02 - 27.99 vs. PDVR 16 months, 95% CI 9.96 - 22.04, p = 0.087). Parameters associated with overall survival were his-topathologically proven venous tumor infiltration, the lymph node status and the necessity of postoperative blood transfusions. Conclusion: PDVR is justified, because peri- and post-operative morbidity and mortality, as well as long-term survival, are comparable to standard PD. Even in case of postoperatively histopathologically confirmed venous tumor infiltration, patients benefit over palliative treatment.
KeywordsPancreasPancreatic CancerExtended PancreatoduodenectomyPancreatoduodenectomy with Venous ResectionBorderline Resectable Pancreatic Cancer
AWMF. (2013) S3-Leitlinie Zum Exokrinen Pankreaskarzinom, Version 1.0. http://www.awmf.org/uploads/tx_szleitlinien/032-010OLl_S3_Exokrines_Pankreaskarzinom_21112013pdf
Yeo, C.J., Cameron, J.L., Lillemoe, K.D., Sohn, T.A., Campbell, K.A., Sauter, P.K., et al. (2002) Pancreaticoduodenectomy with or without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival, Morbidity, and Mortality. Annals of Surgery, 236, 355-366.
Jemal, A., Tiwari, R.C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., et al. (2004) Cancer Statistics, 2004. CA: A Cancer Journal for Clinicians, 54, 8-29. https://doi.org/10.3322/canjclin.54.1.8
Poruk, K.E. and Weiss, M.J. (2015) The Current State of Surgery for Pancreatic Cancer. Minerva Gastroenterologica e Dietologica, 61, 101-115.
Shaib, Y., Davila, J., Naumann, C. and El-Serag, H. (2007) The Impact of Curative Intent Surgery on the Survival of Pancreatic Cancer Patients: A U.S. Population-Based Study. American Journal of Gastroenterology, 102, 1377-1382. https://doi.org/10.1111/j.1572-0241.2007.01202.x
Hartwig, W., Hackert, T., Hinz, U., Gluth, A., Bergmann, F., Strobel, O., et al. (2011) Pancreatic Cancer Surgery in the New Millennium: Better Prediction of Outcome. Annals of Surgery, 254, 311-319. https://doi.org/10.1097/SLA.0b013e31821fd334
Mayo, S.C., Nathan, H., Cameron, J.L., Olino, K., Edil, B.H., Herman, J.M., et al. (2012) Conditional Survival in Patients with Pancreatic Ductal Adenocarcinoma Resected with Curative Intent. Cancer, 118, 2674-2681. https://doi.org/10.1002/cncr.26553
Glanemann, M., Shi, B., Liang, F., Sun, X.G., Bahra, M., Jacob, D., et al. (2008) Surgical Strategies for Treatment of Malignant Pancreatic Tumors: Extended, Standard or Local Surgery? World Journal of Surgical Oncology, 6, 123. https://doi.org/10.1186/1477-7819-6-123
Harrison, L.E., Klimstra, D.S. and Brennan, M.F. (1996) Isolated Portal Vein Involvement in Pancreatic Adenocarcinoma. A Contraindication for Resection? Annals of Surgery, 224, 342-347. https://doi.org/10.1097/00000658-199609000-00010
Ghaneh, P., Costello, E. and Neoptolemos, J.P. (2007) Biology and Management of Pancreatic Cancer. Gut, 56, 1134-1152. https://doi.org/10.1136/gut.2006.113068
Giovinazzo, F., Turri, G., Katz, M.H., Heaton, N. and Ahmed, I. (2016) Meta-Analysis of Benefits of Portal-Superior Mesenteric Vein Resection in Pancreatic Resection for Ductal Adenocarcinoma. British Journal of Surgery, 103, 179-191. https://doi.org/10.1002/bjs.9969
Yekebas, E.F., Bogoevski, D., Cataldegirmen, G., Kunze, C., Marx, A., Vashist, Y.K., et al. (2008) En Bloc Vascular Resection for Locally Advanced Pancreatic Malignancies Infiltrating Major Blood Vessels: Perioperative Outcome and Long-Term Survival in 136 Patients. Annals of Surgery, 247, 300-309. https://doi.org/10.1097/SLA.0b013e31815aab22
Wang, F., Arianayagam, R., Gill, A., Puttaswamy, V., Neale, M., Gananadha, S., et al. (2012) Grafts for Mesenterico-Portal Vein Resections Can Be Avoided during Pancreatoduodenectomy. Journal of the American College of Surgeons, 215, 569-579. https://doi.org/10.1016/j.jamcollsurg.2012.05.034
Tseng, J.F., Raut, C.P., Lee, J.E., Pisters, P.W., Vauthey, J.N., Abdalla, E.K., et al. (2004) Pancreaticoduodenectomy with Vascular Resection: Margin Status and Survival Duration. Journal of Gastrointestinal Surgery, 8, 935-950. https://doi.org/10.1016/j.gassur.2004.09.046
Kelly, K.J., Winslow, E., Kooby, D., Lad, N.L., Parikh, A.A., Scoggins, C.R., et al. (2013) Vein Involvement during Pancreaticoduodenectomy: Is There a Need for Redefinition of “Borderline Resectable Disease”? Journal of Gastrointestinal Surgery, 17, 1209-1217. https://doi.org/10.1007/s11605-013-2178-5
Capussotti, L., Massucco, P., Ribero, D., Vigano, L., Muratore, A. and Calgaro, M. (2003) Extended Lymphadenectomy and Vein Resection for Pancreatic Head Cancer: Outcomes and Implications for Therapy. Archives of Surgery, 138, 1316-1322. https://doi.org/10.1001/archsurg.138.12.1316
Shimada, K., Sano, T., Sakamoto, Y. and Kosuge, T. (2006) Clinical Implications of Combined Portal Vein Resection as a Palliative Procedure in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Head Carcinoma. Annals of Surgical Oncology, 13, 1569-1578. https://doi.org/10.1245/s10434-006-9143-4
Christians, K. and Evans, D.B. (2009) Pancreaticoduodenectomy and Vascular Resection: Persistent Controversy and Current Recommendations. Annals of Surgical Oncology, 16, 789-791. https://doi.org/10.1245/s10434-009-0322-y
Yamada, S., Fujii, T., Sugimoto, H., Nomoto, S., Takeda, S., Kodera, Y., et al. (2013) Aggressive Surgery for Borderline Resectable Pancreatic Cancer: Evaluation of National Comprehensive Cancer Network Guidelines. Pancreas, 42, 1004-1010. https://doi.org/10.1097/MPA.0b013e31827b2d7c
Barbier, L., Turrini, O., Gregoire, E., Viret, F., Le Treut, Y.P. and Delpero, J.R. (2011) Pancreatic Head Resectable Adenocarcinoma: Preoperative Chemoradiation Improves Local Control But Does Not Affect Survival. HPB, 13, 64-69. https://doi.org/10.1111/j.1477-2574.2010.00245.x
Chun, Y.S., Milestone, B.N., Watson, J.C., Cohen, S.J., Burtness, B., Engstrom, P.F., et al. (2010) Defining Venous Involvement in Borderline Resectable Pancreatic Cancer. Annals of Surgical Oncology, 17, 2832-2838. https://doi.org/10.1245/s10434-010-1284-9
Siriwardana, H.P. and Siriwardena, A.K. (2006) Systematic Review of Outcome of Synchronous Portal-Superior Mesenteric Vein Resection during Pancreatectomy for Cancer. British Journal of Surgery, 93, 662-673. https://doi.org/10.1002/bjs.5368
Bassi, C., Dervenis, C., Butturini, G., Fingerhut, A., Yeo, C., Izbicki, J., et al. (2005) Postoperative Pancreatic Fistula: An International Study Group (ISGPF) Definition. Surgery, 138, 8-13. https://doi.org/10.1016/j.surg.2005.05.001
Hartwig, W., Vollmer, C.M., Fingerhut, A., Yeo, C.J., Neoptolemos, J.P., Adham, M., et al. (2014) Extended Pancreatectomy in Pancreatic Ductal Adenocarcinoma: Definition and Consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery, 156, 1-14. https://doi.org/10.1016/j.surg.2014.02.009
Salem, A.I., Alfi, M., Winslow, E., Cho, C.S. and Weber, S.M. (2015) Has Survival Following Pancreaticoduodenectomy for Pancreas Adenocarcinoma Improved over Time? Journal of Surgical Oncology, 112, 643-649. https://doi.org/10.1002/jso.24048
Winter, J.M., Cameron, J.L., Campbell, K.A., Arnold, M.A., Chang, D.C., Coleman, J., et al. (2006) 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience. Journal of Gastrointestinal Surgery, 10, 1199-1210. https://doi.org/10.1016/j.gassur.2006.08.018
Yeo, C.J., Cameron, J.L., Sohn, T.A., Lillemoe, K.D., Pitt, H.A., Talamini, M.A., et al. (1997) Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s: Pathology, Complications, and Outcomes. Annals of Surgery, 226, 248-257. https://doi.org/10.1097/00000658-199709000-00004
Naganuma, T., Isaji, S. and Kawarada, Y. (1998) Staging and Extended Resection for Pancreatic Cancer. Pancreas, 16, 355-362. https://doi.org/10.1097/00006676-199804000-00024
Sasson, A.R., Hoffman, J.P., Ross, E.A., Kagan, S.A., Pingpank, J.F. and Eisenberg, B.L. (2002) En Bloc Resection for Locally Advanced Cancer of the Pancreas: Is It Worthwhile? Journal of Gastrointestinal Surgery, 6, 147-157. https://doi.org/10.1016/S1091-255X(01)00063-4
Yamamoto, T., Yagi, S., Kinoshita, H., Sakamoto, Y., Okada, K., Uryuhara, K., et al. (2015) Long-Term Survival after Resection of Pancreatic Cancer: A Single-Center Retrospective Analysis. World Journal of Gastroenterology, 21, 262-268. https://doi.org/10.3748/wjg.v21.i1.262
Howard, T.J., Krug, J.E., Yu, J., Zyromski, N.J., Schmidt, C.M., Jacobson, L.E., et al. (2006) A Margin-Negative R0 Resection Accomplished with Minimal Postoperative Complications Is the Surgeon’s Contribution to Long-Term Survival in Pancreatic Cancer. Journal of Gastrointestinal Surgery, 10, 1338-1345. https://doi.org/10.1016/j.gassur.2006.09.008
Malik, N.K., May, K.S., Chandrasekhar, R., Wee, W., Flaherty, L., Iyer, R., et al. (2012) Treatment of Locally Advanced Unresectable Pancreatic Cancer: A 10-Year Experience. Journal of Gastrointestinal Oncology, 3, 326-334.
Malleo, G., Maggino, L., Marchegiani, G., Feriani, G., Esposito, A., Landoni, L., et al. (2017) Pancreatectomy with Venous Resection for pT3 Head Adenocarcinoma: Perioperative Outcomes, Recurrence Pattern and Prognostic Implications of Histologically Confirmed Vascular Infiltration. Pancreatology, 17, 847-857. https://doi.org/10.1016/j.pan.2017.08.005
Ramacciato, G., Mercantini, P., Petrucciani, N., Giaccaglia, V., Nigri, G., Ravaioli, M., et al. (2009) Does Portal-Superior Mesenteric Vein Invasion Still Indicate Irresectability for Pancreatic Carcinoma? Annals of Surgical Oncology, 16, 817-825. https://doi.org/10.1245/s10434-008-0281-8
Wagner, M., Redaelli, C., Lietz, M., Seiler, C.A., Friess, H. and Buchler, M.W. (2004) Curative Resection Is the Single Most Important Factor Determining Outcome in Patients with Pancreatic Adenocarcinoma. British Journal of Surgery, 91, 586-594. https://doi.org/10.1002/bjs.4484
Kulemann, B., Hoeppner, J., Wittel, U., Glatz, T., Keck, T., Wellner, U.F., et al. (2015) Perioperative and Long-Term Outcome after Standard Pancreaticoduodenectomy, Additional Portal Vein and Multivisceral Resection for Pancreatic Head Cancer. Journal of Gastrointestinal Surgery, 19, 438-444. https://doi.org/10.1007/s11605-014-2725-8
Yu, X.Z., Li, J., Fu, D.L., Di, Y., Yang, F., Hao, S.J., et al. (2014) Benefit from Synchronous Portal-Superior Mesenteric Vein Resection during Pancreaticoduodenectomy for Cancer: A Meta-Analysis. European Journal of Surgical Oncology, 40, 371-378. https://doi.org/10.1016/j.ejso.2014.01.010
Zhou, Y., Zhang, Z., Liu, Y., Li, B. and Xu, D. (2012) Pancreatectomy Combined with Superior Mesenteric Vein-Portal Vein Resection for Pancreatic Cancer: A Meta-Analysis. World Journal of Surgery, 36, 884-891. https://doi.org/10.1007/s00268-012-1461-z
Delpero, J.R., Boher, J.M., Sauvanet, A., Le Treut, Y.P., Sa-Cunha, A., Mabrut, J.Y., et al. (2015) Pancreatic Adenocarcinoma with Venous Involvement: Is Up-Front Synchronous Portal-Superior Mesenteric Vein Resection Still Justified? A Survey of the Association Francaise de Chirurgie. Annals of Surgical Oncology, 22, 1874-1883. https://doi.org/10.1245/s10434-014-4304-3
Barreto, S.G. and Windsor, J.A. (2016) Justifying Vein Resection with Pancreatoduodenectomy. The Lancet Oncology, 17, e118-e124. https://doi.org/10.1016/S1470-2045(15)00463-5
Ravikumar, R., Sabin, C., Abu Hilal, M., Bramhall, S., White, S., Wigmore, S., et al. (2014) Portal Vein Resection in Borderline Resectable Pancreatic Cancer: A United Kingdom Multicenter Study. Journal of the American College of Surgeons, 218, 401-411. https://doi.org/10.1016/j.jamcollsurg.2013.11.017
Wang, W.L., Ye, S., Yan, S., Shen, Y., Zhang, M., Wu, J., et al. (2015) Pancreaticoduodenectomy with Portal Vein/Superior Mesenteric Vein Resection for Patients with Pancreatic Cancer with Venous Invasion. Hepatobiliary & Pancreatic Diseases International, 14, 429-435. https://doi.org/10.1016/S1499-3872(15)60400-3
Roch, A.M., House, M.G., Cioffi, J., Ceppa, E.P., Zyromski, N.J., Nakeeb, A., et al. (2016) Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma. Journal of Gastrointestinal Surgery, 20, 479-487. https://doi.org/10.1007/s11605-015-3005-y
Banz, V.M., Croagh, D., Coldham, C., Taniere, P., Buckels, J., Isaac, J., et al. (2012) Factors Influencing Outcome in Patients Undergoing Portal Vein Resection for Adenocarcinoma of the Pancreas. European Journal of Surgical Oncology, 38, 72-79. https://doi.org/10.1016/j.ejso.2011.08.134
Cameron, J.L., Crist, D.W., Sitzmann, J.V., Hruban, R.H., Boitnott, J.K., Seidler, A.J., et al. (1991) Factors Influencing Survival after Pancreaticoduodenectomy for Pancreatic Cancer. The American Journal of Surgery, 161, 120-124. https://doi.org/10.1016/0002-9610(91)90371-J
Yeh, J.J., Gonen, M., Tomlinson, J.S., Idrees, K., Brennan, M.F. and Fong, Y. (2007) Effect of Blood Transfusion on Outcome after Pancreaticoduodenectomy for Exocrine Tumour of the Pancreas. British Journal of Surgery, 94, 466-472. https://doi.org/10.1002/bjs.5488
Doi, R., Imamura, M., Hosotani, R., Imaizumi, T., Hatori, T., Takasaki, K., et al. (2008) Surgery versus Radiochemotherapy for Resectable Locally Invasive Pancreatic Cancer: Final Results of a Randomized Multi-Institutional Trial. Surgery Today, 38, 1021-1028. https://doi.org/10.1007/s00595-007-3745-8
Lygidakis, N.J., Singh, G., Bardaxoglou, E., Dedemadi, G., Sgourakis, G., Nestoridis, J., et al. (2004) Mono-Bloc Total Spleno-Pancreaticoduodenectomy for Pancreatic Head Carcinoma with Portal-Mesenteric Venous Invasion. A Prospective Randomized Study. Hepato-Gastroenterology, 51, 427-433.